Next Article in Journal
Effect of Astaxanthin on Human Sperm Capacitation
Previous Article in Journal
Subtilomycin: A New Lantibiotic from Bacillus subtilis Strain MMA7 Isolated from the Marine Sponge Haliclona simulans
Mar. Drugs 2013, 11(6), 1899-1908; doi:10.3390/md11061899
Article

The Extract of Rhodobacter sphaeroides Inhibits Melanogenesis through the MEK/ERK Signaling Pathway

1
, 2
, 3
, 4
, 1
, 1,5
 and 2,6,*
Received: 19 March 2013; in revised form: 26 April 2013 / Accepted: 21 May 2013 / Published: 3 June 2013
View Full-Text   |   Download PDF [507 KB, uploaded 3 June 2013]   |   Browse Figures
Abstract: Reducing hyperpigmentation has been a big issue for years. Even though pigmentation is a normal mechanism protecting skin from UV-causing DNA damage and oxidative stress, it is still an aesthetic problem for many people. Bacteria can produce some compounds in response to their environment. These compounds are widely used in cosmetic and pharmaceutical applications. Some probiotics have immunomodulatory activities and modulate the symptoms of several diseases. Previously, we found that the extracts of Rhodobacter sphaeroides (Lycogen™) inhibited nitric oxide production and inducible nitric-oxide synthase expression in activated macrophages. In this study, we sought to investigate an anti-melanogenic signaling pathway in α-melanocyte stimulating hormone (α-MSH)-treated B16F10 melanoma cells and zebrafish. Treatment with Lycogen™ inhibited the cellular melanin contents and expression of melanogenesis-related protein, including microphthalmia-associated transcription factor (MITF) and tyrosinase in B16F10 cells. Moreover, Lycogen™ reduced phosphorylation of MEK/ERK without affecting phosphorylation of p38. Meanwhile, Lycogen™ decreased zebrafish melanin expression in a dose-dependent manner. These findings establish Lycogen™ as a new target in melanogenesis and suggest a mechanism of action through the ERK signaling pathway. Our results suggested that Lycogen™ may have potential cosmetic usage in the future.
Keywords: Rhodobacter sphaeroides; Lycogen™; melanogenesis Rhodobacter sphaeroides; Lycogen™; melanogenesis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Liu, W.-S.; Kuan, Y.-D.; Chiu, K.-H.; Wang, W.-K.; Chang, F.-H.; Liu, C.-H.; Lee, C.-H. The Extract of Rhodobacter sphaeroides Inhibits Melanogenesis through the MEK/ERK Signaling Pathway. Mar. Drugs 2013, 11, 1899-1908.

AMA Style

Liu W-S, Kuan Y-D, Chiu K-H, Wang W-K, Chang F-H, Liu C-H, Lee C-H. The Extract of Rhodobacter sphaeroides Inhibits Melanogenesis through the MEK/ERK Signaling Pathway. Marine Drugs. 2013; 11(6):1899-1908.

Chicago/Turabian Style

Liu, Wen-Sheng; Kuan, Yu-Diao; Chiu, Kuo-Hsun; Wang, Wei-Kuang; Chang, Fu-Hsin; Liu, Chen-Hsun; Lee, Che-Hsin. 2013. "The Extract of Rhodobacter sphaeroides Inhibits Melanogenesis through the MEK/ERK Signaling Pathway." Mar. Drugs 11, no. 6: 1899-1908.


Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert